Tradestie Institutional Equity Comparison Engine

GCL vs NIVF โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GCL Overall Edge

GCL Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GCL Global Holdings Ltd Ordinary Shares (GCL) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, GCL trades at N/M Forward P/E with -5.5% operating margin (+53.8% YoY revenue) versus NIVF at N/M Forward P/E and -238.2% operating margin (-4.7% YoY). In options structure, GCL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NIVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GCL N/M vs NIVF N/M Fwd P/E
Growth & Margin Winner GCL
Op Margin -5.5% vs -238.2% ยท YoY +53.8% vs -4.7%
Momentum & Technical Winner GCL
1Y -28.4% vs -44.8% ยท 52W Pos 57% vs 5%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GCL NASDAQ
GCL Global Holdings Ltd Ordinary Shares
Services-Prepackaged Software
$1.16
-2.93% 1D
Market Cap $153.0M
1M Return +33.16%
1Y Return -28.4%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 50.0 Fund 33.0 Flow 50.0 Mom 40.0
NIVF NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.20
-11.33% 1D
Market Cap $369,508
1M Return -26.52%
1Y Return -44.83%
Forward P/E N/M
Unified AI Score
45.8 / 100 HOLD
Tech 50.0 Fund 44.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GCL -28.4% NIVF -44.83% Spread: +16.43 pp (GCL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GCL TTM Op. Margin: -5.5% NIVF TTM Op. Margin: -238.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GCL vs NIVF. Trailing 12-month operating profitability (GCL -5.5% vs NIVF -238.2%) and valuation multiples (GCL N/M vs NIVF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GCL (5) vs NIVF (3)
Institutional Metric GCL NIVF Criterion Row Winner
Market Capitalization Scale $153.0M $369,508 Larger Scale GCL
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +53.8% -4.7% Higher Growth GCL
Operating Margin (TTM) Profitability -5.5% -238.2% Higher Margin GCL
Net Profit Margin Profitability -10.5% 24.2% Higher Margin NIVF
Return on Equity (ROE) Capital Efficiency -67.3% 5.5% Higher ROE NIVF
52-Week Range Position Momentum 57% ($0โ€“$2) 5% ($0โ€“$3) Stronger Trend GCL
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 75% Vol 0.07ฮฒ ยท 3093% Vol Lower Realized Risk GCL
Unified Institutional Score Composite Signal 31.6 / 100 (SELL) 45.8 / 100 (HOLD) Higher Composite NIVF

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GCL vs NIVF Buy Guide
GCL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NIVF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NIVF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GCL nor NIVF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.